AI-Generated Drug Enters Trial 🧪 // Slot-TTA for Visual Detectors 🔍 // Catastrophic AI Risks ⚠️

From the first fully AI-generated drug entering clinical trials to a new method for improving out-of-distribution performance of visual detectors, there's plenty to pique your interest. The OBELISC dataset is also discussed, which could have important implications for training large multimodal models. Finally, the potential catastrophic risks associated with AI are explored, with practical suggestions proposed for mitigating these dangers. Contact:  [email protected] Timestamps: 00:34 Introduction 01:33 How AI Influences What You See on Facebook and Instagram 03:13 The first fully A.I.-generated drug enters clinical trials in human patients 05:27 Your guide to AI: July 2023 07:00 Fake sponsor 08:52 Test-time Adaptation with Slot-Centric Models 10:23 OBELISC: An Open Web-Scale Filtered Dataset of Interleaved Image-Text Documents 12:05 An Overview of Catastrophic AI Risks 14:07 Outro